These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 728864)

  • 1. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery.
    Hanna MG; Peters LC
    Cancer; 1978 Dec; 42(6):2613-25. PubMed ID: 728864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG; Peters LC
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active specific immunotherapy of established micrometastases with BCG plus tumor cell vaccines: effective treatment of BCG side effects with isoniazid.
    Hanna MG; Pollack VA; Peters LC; Hoover HC
    Cancer; 1982 Feb; 49(4):659-64. PubMed ID: 7055781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs.
    Peters LC; Hanna MG
    J Natl Cancer Inst; 1980 Jun; 64(6):1521-5. PubMed ID: 6990075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of metastases enhances subsequent chemotherapy.
    Hanna MG; Key ME
    Science; 1982 Jul; 217(4557):367-9. PubMed ID: 6283635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
    Key ME; Brandhorst JS; Hanna MG
    J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.
    Ashley MP; Zbar B; Hunter JT; Rapp HJ; Sugimoto T
    Cancer Res; 1980 Nov; 40(11):4197-203. PubMed ID: 7471060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors.
    Peters LC; Brandhorst JS; Hanna MG
    Cancer Res; 1979 Apr; 39(4):1353-60. PubMed ID: 217533
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):863-9. PubMed ID: 6944553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM; Riggs CW; Hanna MG
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations.
    Bartlett GL; Kreider JW; Purnell DM; Katsilas DC
    Cancer; 1980 Aug; 46(3):488-96. PubMed ID: 6994867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific vaccine effective against stage I and stage II malignant disease in guinea pigs. Effect of variations in preparations and storage.
    Yarkoni E; Hunter JT; Sukumar S
    Cancer Immunol Immunother; 1982; 14(2):92-5. PubMed ID: 6965232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor.
    Hanna MG; Peters LC
    Cancer; 1975 Oct; 36(4):1298-304. PubMed ID: 1175128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P; Mathews HL
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.
    Yarkoni E; Rapp HJ
    Infect Immun; 1981 Jan; 31(1):514-6. PubMed ID: 7216457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic trials of murine and guinea-pig solid tumors by oral administration of BCG.
    Tokunaga T; Taguchi S; Chino F; Murohashi T
    Jpn J Med Sci Biol; 1979 Feb; 32(1):1-18. PubMed ID: 470220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery.
    Zbar B; Canti G; Ashley MP; Rapp HJ; Hunter JT; Ribi E
    Cancer Res; 1979 May; 39(5):1597-603. PubMed ID: 427799
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
    Yarkoni E; Rapp HJ
    Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.